WELCOME SUMMIT 2025
The 9th Annual E-Cigarette Summit returns to Washington, D.C., on May 19, 2025. Drawing on current experiences from around the world, the Summit facilitates thoughtful analysis of the scientific evidence on e-cigarettes and novel nicotine products. During an unprecedented period of disruption and change, it offers a timely opportunity to explore what has happened and what could happen next in tobacco science, policy, and regulation.
Prof Scott J. Leischow will deliver the opening keynote and highlight the context and conflicts surrounding the responsible dissemination of tobacco harm reduction information from public health and governmental organizations.
Ahead of the first panel discussion, Prof Thomas Glynn will host a conversation with veteran CTP director Mitch Zeller and explore the implications of recent Trump Administration actions within the regulatory, policy, and scientific landscapes and discuss what this might mean for public health and the future of a comprehensive tobacco plan in the US.
Prof Robin Mermelstein will deliver the closing keynote and propose the pillars of an approach to finding a path forward in the face of multifaceted and multisectorial threats that could hamper previous success in reducing cigarette smoking for all.
WE ARE HYBRID
The E-Cigarette Summit USA is hybrid and offers live and on-demand viewing option for those who are unable to join us in person. We will “live stream” the Summit as per the agenda (US EST) Individual videos of speaker presentations and the panel discussions will be added to the virtual platform within 48 hours of the live event for you to watch/re-watch later. The app will be live for 3 months after the event.
SUMMIT CHAIRS 2025
SUMMIT CHAIR
Prof Thomas J. Glynn
Prof Thomas J. Glynn
Adjunct Lecturer, Stanford Prevention Research Center
Stanford University School of Medicine
SUMMIT CHAIR
Prof Robin J. Mermelstein, PhD
Prof Robin J. Mermelstein, PhD
Distinguished Professor of Psychology and IHRP Director
University of Illinois, Chicago
SUMMIT SPEAKERS 2025
Prof Thomas J. Glynn, PhD
Adjunct Lecturer
Stanford Prevention Research Centre, Stanford University School of Medicine
Prof Robin Mermelstein
Distinguished Professor of Psychology and IHRP Director
University of Illinois, Chicago
Mitch Zeller J.D
Retired Director, Center for Tobacco Products (CTP)
The Food & Drug Administration (FDA)
Martin Dockrell
Former Tobacco Control Programme Lead
(Retired) The Office of Health Improvement and Disparities (OHID), UK
Dr. Nancy A. Rigotti, MD
Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
Prof Dorothy K. Hatsukami
Professor, Department of Psychiatry and Behavioral Sciences
University of Minnesota
Christian Matthew Saenz
Doctoral Candidate, Department of Economics at the Andrew Young School of Policy Studies
Georgia State University
Dr Tracy Smith, PhD
Associate Professor, Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina (MUSC)
Prof Neal L. Benowitz MD
Professor of Medicine Emeritus (Active)
University of California, San Franciso
Prof Lion Shahab
Professor of Health Psychology & Head of Research
Department of Behavioural Science and Health, University College London (UCL)
Dr Jamie Hartmann-Boyce
Assistant Professor in Health Promotion and Policy
University of Massachusetts Amherst
Prof Scott Sherman
Professor of Population Health, Medicine and Psychiatry
NYU Grossman School of Medicine
Prof Megan Piper, PhD
Professor, Division of General Internal Medicine, Department of Medicine
University of Wisconsin Madison
Asst Prof Jamie Tam, PhD, MPH
Assistant Professor of Public Health (Health Policy)
Yale School of Public Health
Dr Sharon Cox
Principal Research Fellow, Tobacco and Alcohol Research Group
University College London (UCL)
Prof Ken Warner
Avedis Donabedian Distinguished University Professor Emeritus and Dean Emeritus
School of Public Health, University of Michigan
Dr Steve Cook, PhD
Assistant Research Scientist, School of Public Health Epidemiology
University of Michigan
If you cannot see the full list of speakers required for this page please make sure you have ordered all speakers in your custom list.
Edit Custom Order Here »
Only administrators can see this message
WHAT QUESTIONS WILL BE EXPLORED?
The E-Cigarette Summit US provides an evidence based environment that encourages open and respectful dialogue on the key science and current public health topics. The format includes high level briefings from global experts followed by panel discussions and audience Q&A.
- Stop the swap: A new hazard in tobacco control in the UK
- Is nicotine the new smoking, or the end of smoking? Lessons from New Zealand
- Responsible dissemination: Exploring the role of public health organizations regarding tobacco harm reduction
- Maximizing public health in the context of product standards on combusted products
- Can the Trump Administration Resurrect the FDA’s 2017 Comprehensive Plan in 2025?
- E-cigarette Regulation and Mortality
- Industry’s Attitude Toward Potential Reforms of FDA’s Nicotine and Tobacco Policy
- Maximizing the impact of non-combusted tobacco products for harm reduction: the right products for the right people
- Fixing the broken and lawless tobacco and nicotine market
- What we can and cannot conclude about the harms of vaping – the good, the bad and the ugly
- The Benefits and Risks of Oral Nicotine Pouches: Implications for Public Health
- Vaping to quit smoking, not smoking to quit vaping: The importance of sticking to the facts
- Communicating smoking and vaping cessation
- Thinking through a paradigm for evaluating novel nicotine products: What have we learned and what do we need to know?
- Health and economic implications of a nicotine product standard
- The Past is Prologue: Health effects research in an evolving nicotine and tobacco marketplace
- Four Completely Different Kinds of Evidence that Vaping Increases Adult Smoking Cessation
- Strengthening the Evidence: Triangulation, Replication, and the Role of E-Cigarettes in Smoking Cessation
WHO SHOULD ATTEND
The E-Cigarette Summit US is particularly relevant to:
- Regulators and policy advisors
- Health providers and public health advocates
- National, state and local legislators and their staffs
- Public health professionals
- Scientific/research community
- Medical and health professionals
- e-cigarette industry stakeholders
WHO SHOULD ATTEND
- Regulators and policy advisors
- Health providers and public health advocates
- National, state and local legislators and their staffs
- Public health professionals
- Scientific/research community
- Medical and health professionals
- e-cigarette industry stakeholders
